Independent mechanisms for macrophage binding and macrophage phagocytosis of damaged erythrocytes. Evidence of receptor cooperativity

Arteriosclerosis, Thrombosis, and Vascular Biology
G R SambranoD Steinberg

Abstract

The binding and phagocytosis of oxidatively damaged red blood cells (OxRBCs) by mouse peritoneal macrophages can be inhibited by oxidatively modified LDL (OxLDL), implying some commonality at their receptor-binding domains. Studies from many different laboratories support the view that OxRBC binding is due to the disruption of plasma membrane phospholipid asymmetry and the subsequent exposure of phosphatidylserine (PS) on the outer membrane leaflet. Presumably, oxidation of LDL creates a surface structure on it in some way homologous to the PS-rich domain on OxRBCs. Apoptotic cells in some instances are also recognized because of PS exposure on the outer leaflet of the membrane, and apoptotic cells are a common feature of atherosclerotic lesions. In the present studies, the mechanisms of binding and internalization of cells recognized by virtue of their membrane PS were studied using OxRBCs or vanadate-treated erythrocytes (VaRBCs) as models. Disruption of phospholipid asymmetry with vanadate produced cells that were bound by macrophages in the same divalent cation-dependent manner as OxRBCs. However, whereas OxRBCs were rapidly phagocytosed, VaRBCs were not. Stimulation of mouse macrophages with phorbol myristate acetate resul...Continue Reading

References

Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·S K BasuM S Brown
Jan 1, 1979·Annual Review of Biochemistry·J A Op den Kamp
May 4, 1978·Biochimica Et Biophysica Acta·C W HaestB Deuticke
Feb 1, 1977·The Journal of Experimental Medicine·A G Ehlenberger, V Nussenzweig
Jan 1, 1992·Annual Review of Biophysics and Biomolecular Structure·P F Devaux
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Dec 1, 1988·American Journal of Hematology·R P Hebbel, W J Miller
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L McEvoyR A Schlegel
Oct 1, 1982·The Journal of Experimental Medicine·S D Wright, S C Silverstein
Jun 15, 1994·Biochemical and Biophysical Research Communications·Z LiuR J Looney
Jul 7, 1995·The Journal of Biological Chemistry·A RigottiM Krieger
Oct 1, 1995·The Journal of Clinical Investigation·S NozakiK Kameda-Takemura
May 1, 1995·The Journal of Clinical Investigation·M R BennettS M Schwartz
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·G R Sambrano, D Steinberg
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·G R SambranoD Steinberg
Feb 1, 1996·Current Opinion in Immunology·A M Pearson
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·N PlattS Gordon
Mar 1, 1995·Trends in Cell Biology·S Greenberg

❮ Previous
Next ❯

Citations

Feb 25, 2014·Microbes and Infection·Laura E CollinsChristine E Loscher
Mar 18, 2004·Antioxidants & Redox Signaling·Bengt Fadeel
Mar 29, 2001·Journal of Hematotherapy & Stem Cell Research·L HegyiJ N Skepper
Nov 6, 2009·Antioxidants & Redox Signaling·Irena LevitanPapasani V Subbaiah
Mar 22, 2003·The Korean Journal of Internal Medicine·Hong Sook KoWang Seong Ryu
Jul 30, 2002·Diabetes·Bronwyn A O'BrienDiane T Finegood
Dec 10, 2002·Annual Review of Physiology·Krishnakumar Balasubramanian, Alan J Schroit
Mar 17, 2000·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·M D CarvalhoE C Quintão
Nov 16, 2007·Medicinal Research Reviews·R L TiwariM K Barthwal
Sep 6, 2001·Cell Death and Differentiation·R A Schlegel, P Williamson
Jun 6, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·V E KaganB Fadeel
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Valerian E KaganBengt Fadeel
Sep 9, 2005·The Biochemical Journal·Jane E MurphySreenivasan Ponnambalam
Mar 31, 2018·Expert Opinion on Drug Discovery·Isabelle CoornaertWim Martinet
Oct 29, 2019·Expert Review of Hematology·Fatemeh NorooznezhadAmir Hossein Norooznezhad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.